4//SEC Filing
Thomas Dolca 4
Accession 0001209191-22-032960
CIK 0001435049other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:25 PM ET
Size
8.0 KB
Accession
0001209191-22-032960
Insider Transaction Report
Form 4
Thomas Dolca
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-26+13,300→ 13,300 totalExercise: $13.88Exp: 2032-05-25→ Common Stock (13,300 underlying) - Award
Restricted Stock Unit
2022-05-26+3,300→ 3,300 totalExp: 2023-05-26→ Common Stock (3,300 underlying)
Footnotes (3)
- [F1]100% of the stock option will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]100% of the RSUs will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001768239
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 6:25 PM ET
- Size
- 8.0 KB